APOE ε4 and risk for Alzheimer's disease: Do regionally distributed white matter hyperintensities play a role?

Alzheimer's and Dementia

Volumn 10, Issue 6, 2014, Pages 619-629

  Brickman, Adam M ^a,b   Schupf, Nicole ^a,b,c   Manly, Jennifer J ^a,b   Stern, Yaakov ^a,b   Luchsinger, José A ^a,c   Provenzano, Frank A ^a   Narkhede, Atul ^a   Razlighi, Qolamreza ^a   Collins Praino, Lyndsey ^a   Artero, Sylvaine ^d,e   Akbaraly, Tasnime N ^d,e,f   Ritchie, Karen ^d,e,f   Mayeux, Richard ^a,b,c   Portet, Florence ^d,e  

^a Columbia University ^*  (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Department of Medicine   (United States)

^d Montpellier 1 University   (France)

^e UNIV MONTPELLIER   (France)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; APOE; White matter hyperintensities

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; COMORBIDITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TEMPORAL LOBE; WHITE MATTER HYPERINTENSITY; ANALYSIS OF VARIANCE; GENETICS; IMAGE PROCESSING; LONGITUDINAL STUDY; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84927128692     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.07.155     Document Type: Article

References (56)

1. P.B. Gorelick Risk factors for vascular dementia and Alzheimer disease Stroke 35 Suppl 1 2004 2620 2622
2. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
3. J. Nalbantoglu, B.M. Gilfix, P. Bertrand, Y. Robitaille, S. Gauthier, and D.S. Rosenblatt Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies Ann Neurol 36 1994 889 895
4. M.X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland, and R. Lantigua The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics JAMA 279 1998 751 755
5. D.M. Holtzman, K.R. Bales, T. Tenkova, A.M. Fagan, M. Parsadanian, and L.J. Sartorius Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease Proc Natl Acad Sci U S A 97 2000 2892 2897
6. J. Naslund, J. Thyberg, L.O. Tjernberg, C. Wernstedt, A.R. Karlstrom, and N. Bogdanovic Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain Neuron 15 1995 219 228
7. G.W. Rebeck, J.S. Reiter, D.K. Strickland, and B.T. Hyman Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions Neuron 11 1993 575 580
8. R. Deane, A. Sagare, K. Hamm, M. Parisi, S. Lane, and M.B. Finn apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain J Clin Invest 118 2008 4002 4013
9. W.J. Jagust, and S.M. Landau Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging J Neurosci 32 2012 18227 18233
10. B.D. Zipser, C.E. Johanson, L. Gonzalez, T.M. Berzin, R. Tavares, and C.M. Hulette Microvascular injury and blood-brain barrier leakage in Alzheimer's disease Neurobiol Aging 28 2007 977 986
11. B.V. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders Nat Rev Neurosci 12 2011 723 738
12. K. Amar, S. MacGowan, G. Wilcock, T. Lewis, and M. Scott Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population Int J Geriatr Psychiatry 13 1998 585 590
13. R. Barber, A. Gholkar, P. Scheltens, C. Ballard, I.G. McKeith, and C.M. Morris Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias Arch Neurol 56 1999 961 965
14. M. Bornebroek, J. Haan, S.G. Van Duinen, M.L. Maat-Schieman, M.A. Van Buchem, and E. Bakker Dutch hereditary cerebral amyloid angiopathy: structural lesions and apolipoprotein E genotype Ann Neurol 41 1997 695 698
15. L. Bronge, S.E. Fernaeus, M. Blomberg, M. Ingelson, L. Lannfelt, and B. Isberg White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype Dement Geriatr Cogn Disord 10 1999 89 96
16. F.E. de Leeuw, F. Richard, J.C. de Groot, C.M. van Duijn, A. Hofman, and J. Van Gijn Interaction between hypertension, apoE, and cerebral white matter lesions Stroke 35 2004 1057 1060
17. N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia Stroke 31 2000 1263 1268
18. S. Schilling, A.L. DeStefano, P.S. Sachdev, S.H. Choi, K.A. Mather, and C.D. DeCarli APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis Neurology 81 2013 292 300
19. J.A. Luchsinger, A.M. Brickman, C. Reitz, S.J. Cho, N. Schupf, and J.J. Manly Subclinical cerebrovascular disease in mild cognitive impairment Neurology 73 2009 450 456
20. F. Portet, A.M. Brickman, Y. Stern, N. Scarmeas, J. Muraskin, and F.A. Provenzano Metabolic syndrome and localization of white matter hyperintensities in the elderly population Alzheimers Dement 8 5 Suppl 2012 S88 95
21. A.M. Brickman, L.S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, and M.S. Albert Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease Arch Neurol 65 2008 1202 1208
22. A.M. Brickman, F.A. Provenzano, J. Muraskin, J.J. Manly, S. Blum, and Z. Apa Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community Arch Neurol 69 2012 1621 1627
23. A.M. Brickman, J. Muraskin, and M.E. Zimmerman Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci 11 2009 181 190
24. M.X. Tang, P. Cross, H. Andrews, D.M. Jacobs, S. Small, and K. Bell Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan Neurology 56 2001 49 56
25. A.M. Brickman, N. Schupf, J.J. Manly, J.A. Luchsinger, H. Andrews, and M.X. Tang Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan Arch Neurol 65 2008 1053 1061
26. K. Ritchie, S. Artero, I. Beluche, M.L. Ancelin, A. Mann, and A.M. Dupuy Prevalence of DSM-IV psychiatric disorder in the French elderly population Br J Psychiatry 184 2004 147 152
27. A.M. Brickman, J.R. Sneed, F.A. Provenzano, E. Garcon, L. Johnert, and J. Muraskin Quantitative approaches for assessment of white matter hyperintensities in elderly populations Psychiatry Res 193 2011 101 106
28. C. Rorden, and M. Brett Stereotaxic display of brain lesions Behav Neurol 12 2000 191 200
29. A.M. Brickman, A. Zahra, J. Muraskin, J. Steffener, C.M. Holland, and C. Habeck Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging Psychiatry Res 172 2009 117 120
30. R. Mayeux, R. Ottman, G. Maestre, C. Ngai, M.X. Tang, and H. Ginsberg Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease Neurology 45 3 Pt 1 1995 555 557
31. J.A. Luchsinger, C. Reitz, L.S. Honig, M.X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 2005 545 551
32. M. Mortamais, C. Reynes, A.M. Brickman, F.A. Provenzano, J. Muraskin, and F. Portet Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia PloS one 8 2013 e56972
33. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS J Lipid Res 50 Suppl 2009 S183 S188
34. S.H. Hafsteinsdottir, G. Eiriksdottir, S. Sigurdsson, T. Aspelund, T.B. Harris, and L.J. Launer Brain tissue volumes by APOE genotype and leisure activity - the AGES-Reykjavik Study Neurobiol Aging 33 2012 829.e1 829.e8
35. I. Skoog, C. Hesse, O. Aevarsson, S. Landahl, J. Wahlstrom, and P. Fredman A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality J Neurol Neurosurg Psychiatry 64 1998 37 43
36. N. Raz, Y. Yang, C.L. Dahle, and S. Land Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants Biochim Biophys Acta 1822 2012 361 369
37. C. Reitz, and R. Mayeux Genetics of Alzheimer's Disease in Caribbean Hispanic and African American Populations Biol Psychiatry 75 2014 534 541
38. F.-E. de Leeuw, J.C. de Groot, E. Achten, M. Oudkerk, L.M.P. Ramos, and R. Heijboer Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study J Neurology Neurosurg Psychiatry 70 2001 9 14
39. M. Yoshita, E. Fletcher, D. Harvey, M. Ortega, O. Martinez, and D.M. Mungas Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD Neurology 67 2006 2192 2198
40. C. Coffey, J.F. Lucke, J.A. Saxton, G. Ratcliff, L.J. Unitas, and B. Billig Sex differences in brain aging: A quantitative magnetic resonance imaging study Arch Neurol 55 1998 169 179
41. E. Imabayashi, H. Matsuda, T. Asada, T. Ohnishi, S. Sakamoto, and S. Nakano Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT J Nucl Med 45 2004 1450 1457
42. K. Ishii, H. Sasaki, A.K. Kono, N. Miyamoto, T. Fukuda, and E. Mori Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies Eur J Nucl Med Mol Imaging 32 2005 959 963
43. W.J. Jagust, J.L. Eberling, C.C. Wu, A. Finkbeiner, D. Mungas, and P.E. Valk Brain function and cognition in a community sample of elderly Latinos Neurology 59 2002 378 383
44. R. Ossenkoppele, W.M. van der Flier, M.D. Zwan, S.F. Adriaanse, R. Boellaard, and A.D. Windhorst Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia Neurology 80 2013 359 365
45. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
46. H. Braak, and E. Braak Evolution of the neuropathology of Alzheimer's disease Acta Neurol Scand Suppl 165 1996 3 12
47. H.V. Vinters, and J.J. Gilbert Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes Stroke 14 1983 924 928
48. J.D. Fryer, K. Simmons, M. Parsadanian, K.R. Bales, S.M. Paul, and P.M. Sullivan Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model J Neurosci 25 2005 2803 2810
49. S.A. Small, S.A. Schobel, R.B. Buxton, M.P. Witter, and C.A. Barnes A pathophysiological framework of hippocampal dysfunction in ageing and disease Nat Rev 12 2011 585 601
50. U.A. Khan, L. Liu, F.A. Provenzano, D.E. Berman, C.P. Profaci, and R. Sloan Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease Nat Neurosci 17 2014 304 311
51. D. Erten-Lyons, R. Woltjer, J. Kaye, N. Mattek, H.H. Dodge, and S. Green Neuropathologic basis of white matter hyperintensity accumulation with advanced age Neurology 81 2013 977 983
52. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, and P.S. Aisen Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
53. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
54. V.A. Guzman, O.T. Carmichael, C. Schwarz, G. Tosto, M.E. Zimmerman, and A.M. Brickman White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment Alzheimers Dement 9 Suppl 1 2013 S124 S131
55. F.A. Provenzano, J. Muraskin, G. Tosto, A. Narkhede, B.T. Wasserman, and E.Y. Griffith White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol 2013 1 7
56. M.-X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland, and R. Lantigua The APOE-e4 allele and the risk of Alzheimer's disease among African Americans, whites, and Hispanics JAMA 279 1998 751 755